Marc Pretze
Impact in
- Pharmaceutical Science top 5%
- Fluorine in Organic Chemistry
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Radiopharmaceutical Chemistry and Applications 14
- Medical Imaging Techniques and Applications 9
-
- Chemical Synthesis and Analysis 9
- Co-authors
- Constantin Mamat (10 shared papers)Björn Wängler (12 shared papers)Carmen Wängler (11 shared papers)Martin Köckerling (4 shared papers)Jörg Kotzerke (12 shared papers)Philipp Große-Gehling (1 shared paper)Jörg Steinbach (4 shared papers)Jens Pietzsch (4 shared papers)
- Journals
- Pharmaceuticals (5 papers)European Journal of Nuclear Medicine and Molecular Imaging (3 papers)Molecules (2 papers)Bioconjugate Chemistry (2 papers)EJNMMI Radiopharmacy and Chemistry (2 papers)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Marc Pretze
36 papers receiving 584 citations
Peers
Comparison fields: 5 of 74
- Pharmaceutical Science 93
- Radiology, Nuclear Medicine and Imaging 286
- Organic Chemistry 161
- Oncology 153
- Immunology and Allergy 32
Countries citing papers authored by Marc Pretze
This map shows the geographic impact of Marc Pretze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Pretze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Pretze more than expected).
Fields of papers citing papers by Marc Pretze
This network shows the impact of papers produced by Marc Pretze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Pretze. The network helps show where Marc Pretze may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Pretze, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 68 | |
| 2 | 2021 | 56 | |
| 3 | 2014 | 48 | |
| 4 | 2011 | 40 | |
| 5 | 2010 | 38 | |
| 6 | 2012 | 29 | |
| 7 | 2024 | 28 | |
| 8 | 2013 | 25 | |
| 9 | 2013 | 24 | |
| 10 | 2019 | 24 | |
| 11 | 2016 | 22 | |
| 12 | 2018 | 19 | |
| 13 | 2023 | 17 | |
| 14 | 2020 | 15 | |
| 15 | 2016 | 15 | |
| 16 | 2021 | 14 | |
| 17 | 2014 | 12 | |
| 18 | 2021 | 11 | |
| 19 | 2010 | 11 | |
| 20 | 2016 | 10 |
About Marc Pretze
Marc Pretze is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Organic Chemistry, having authored 37 papers that have together received 589 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (14 papers), Medical Imaging Techniques and Applications (9 papers), Chemical Synthesis and Analysis (9 papers), Click Chemistry and Applications (6 papers), Neuroendocrine Tumor Research Advances (5 papers), HER2/EGFR in Cancer Research (4 papers), Nanoparticle-Based Drug Delivery (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Pharmaceutical Science (93 citations), Radiology, Nuclear Medicine and Imaging (286 citations), Organic Chemistry (161 citations), Oncology (153 citations) and Immunology and Allergy (32 citations). Marc Pretze has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Constantin Mamat, Björn Wängler, Carmen Wängler, Martin Köckerling, Jörg Kotzerke, Philipp Große-Gehling, Jörg Steinbach, Jens Pietzsch, Tim Peppel and Frank Wuest. Their work appears in journals such as Pharmaceuticals, European Journal of Nuclear Medicine and Molecular Imaging, Molecules, Bioconjugate Chemistry and EJNMMI Radiopharmacy and Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.